Literature DB >> 14982763

Quantitative evaluation of the therapeutic effects of antibiotics using silkworms infected with human pathogenic microorganisms.

Hiroshi Hamamoto1, Kenji Kurokawa, Chikara Kaito, Koushirou Kamura, Iony Manitra Razanajatovo, Hiroyuki Kusuhara, Tomofumi Santa, Kazuhisa Sekimizu.   

Abstract

The injection of bacteria (Staphylococcus aureus, Stenotrophomonas maltophilia) or true fungi (Candida albicans, Candida tropicalis) that are pathogenic to humans into the silkworm hemolymph leads to death of the larvae within 2 days. Antibiotics used for clinical purposes have therapeutic effects on silkworms infected with these pathogens. The 50% effective doses obtained by injection into the silkworm hemolymph are consistent with those reported for mice. Injection of vancomycin and kanamycin into the silkworm hemolymph was effective, but oral administration was not. Chloramphenicol, which is effective by oral administration, appeared in the silkworm hemolymph soon after injection into the midgut, whereas vancomycin did not. Isolated midgut membranes were impermeable to vancomycin. Thus, the ineffectiveness of oral administration of vancomycin to silkworms is due to a lack of intestinal absorption.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982763      PMCID: PMC353159          DOI: 10.1128/AAC.48.3.774-779.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Increase in resistance of methicillin-resistant Staphylococcus aureus to beta-lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals.

Authors:  N AKimitsu; H Hamamoto; R Inoue; M Shoji; A Akamine; K Takemori; N Hamasaki; K Sekimizu
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

2.  Production of uricase by Candida tropicalis using n-alkane as a substrate.

Authors:  A Tanaka; M Yamamura; S Kawamoto; S Fukui
Journal:  Appl Environ Microbiol       Date:  1977-10       Impact factor: 4.792

3.  In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections.

Authors:  C W Ford; J C Hamel; D M Wilson; J K Moerman; D Stapert; R J Yancey; D K Hutchinson; M R Barbachyn; S J Brickner
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

4.  Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis.

Authors:  F Ikeda; Y Wakai; S Matsumoto; K Maki; E Watabe; S Tawara; T Goto; Y Watanabe; F Matsumoto; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

5.  Primary structure of sarcotoxin I, an antibacterial protein induced in the hemolymph of Sarcophaga peregrina (flesh fly) larvae.

Authors:  M Okada; S Natori
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

6.  Drosophila Thor participates in host immune defense and connects a translational regulator with innate immunity.

Authors:  A Bernal; D A Kimbrell
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

7.  Disintegration of the peritrophic membrane of silkworm larvae due to spindles of an entomopoxvirus.

Authors:  Wataru Mitsuhashi; Kazuhisa Miyamoto
Journal:  J Invertebr Pathol       Date:  2003-01       Impact factor: 2.841

8.  Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model.

Authors:  S Mahajan-Miklos; M W Tan; L G Rahme; F M Ausubel
Journal:  Cell       Date:  1999-01-08       Impact factor: 41.582

9.  Silkworm larvae as an animal model of bacterial infection pathogenic to humans.

Authors:  Chikara Kaito; Nobuyoshi Akimitsu; Haruo Watanabe; Kazuhisa Sekimizu
Journal:  Microb Pathog       Date:  2002-04       Impact factor: 3.738

10.  The pharmacokinetics of the interstitial space in humans.

Authors:  David G Levitt
Journal:  BMC Clin Pharmacol       Date:  2003-07-30
View more
  52 in total

Review 1.  Drosophila and Galleria insect model hosts: new tools for the study of fungal virulence, pharmacology and immunology.

Authors:  Michail S Lionakis
Journal:  Virulence       Date:  2011 Nov-Dec       Impact factor: 5.882

2.  Regulation of exoprotein gene expression by the Staphylococcus aureus cvfB gene.

Authors:  Yasuhiko Matsumoto; Chikara Kaito; Daisuke Morishita; Kenji Kurokawa; Kazuhisa Sekimizu
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

3.  Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus.

Authors:  Fumiaki Tabuchi; Yasuhiko Matsumoto; Masaki Ishii; Keita Tatsuno; Mitsuhiro Okazaki; Tomoaki Sato; Kyoji Moriya; Kazuhisa Sekimizu
Journal:  J Antibiot (Tokyo)       Date:  2017-02-15       Impact factor: 2.649

4.  Induction of virulence gene expression in Staphylococcus aureus by pulmonary surfactant.

Authors:  Kenichi Ishii; Tatsuo Adachi; Jyunichiro Yasukawa; Yutaka Suzuki; Hiroshi Hamamoto; Kazuhisa Sekimizu
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

5.  Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane.

Authors:  Hiroshi Hamamoto; Makoto Urai; Kenichi Ishii; Jyunichiro Yasukawa; Atmika Paudel; Motoki Murai; Takuya Kaji; Takefumi Kuranaga; Kenji Hamase; Takashi Katsu; Jie Su; Tatsuo Adachi; Ryuji Uchida; Hiroshi Tomoda; Maki Yamada; Manabu Souma; Hiroki Kurihara; Masayuki Inoue; Kazuhisa Sekimizu
Journal:  Nat Chem Biol       Date:  2014-12-08       Impact factor: 15.040

6.  Perspective: The age of the phage.

Authors:  Shigenobu Matsuzaki; Jumpei Uchiyama; Iyo Takemura-Uchiyama; Masanori Daibata
Journal:  Nature       Date:  2014-05-01       Impact factor: 49.962

7.  Display of human proinsulin on the Bacillus subtilis spore surface for oral administration.

Authors:  Fan Feng; Ping Hu; Liang Chen; Qi Tang; Chaoqun Lian; Qin Yao; Keping Chen
Journal:  Curr Microbiol       Date:  2013-02-05       Impact factor: 2.188

8.  Discovery of a new antifungal agent ASP2397 using a silkworm model of Aspergillus fumigatus infection.

Authors:  Ikuko Nakamura; Ryuichi Kanasaki; Koji Yoshikawa; Shigetada Furukawa; Akihiko Fujie; Hiroshi Hamamoto; Kazuhisa Sekimizu
Journal:  J Antibiot (Tokyo)       Date:  2016-08-31       Impact factor: 2.649

9.  Use of silkworms for identification of drug candidates having appropriate pharmacokinetics from plant sources.

Authors:  Yukihiro Asami; Ryo Horie; Hiroshi Hamamoto; Kazuhisa Sekimizu
Journal:  BMC Pharmacol       Date:  2010-06-11

10.  Antioxidative properties of 4-methylumbelliferone are related to antibacterial activity in the silkworm (Bombyx mori) digestive tract.

Authors:  Yan Fang; Hua Wang; Wenjuan Zhu; Lu Wang; Hengjiang Liu; Xu Xu; Weimin Yin; Yanghu Sima; Shiqing Xu
Journal:  J Comp Physiol B       Date:  2014-07-06       Impact factor: 2.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.